PHARMO, part of Lumanity will be presenting during the conference.
Monday, May 11, 2026
– Oral presentation OP29: “The effect of the implementation of a deprescribing program regarding glucose-lowering medication in primary care on diabetes complications in overtreated elderly with type 2 diabetes: a randomized controlled intervention study”
– Poster PP21: “Evaluating the impact of the implementation of a deprescribing program regarding glucose-lowering medication in primary care”
Connect with our staff or schedule a time to meet during the meeting by reaching out to contact@lumanity.com.